Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2

5(62.5%)

N/A

2(25.0%)

Phase 1

1(12.5%)

8Total

Phase 2(5)

N/A(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07111884Recruiting

GMMG Multiple Myeloma Registry

Role: collaborator

NCT04865250Phase 2Recruiting

Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC

Role: collaborator

NCT03157934Unknown

Schlaganfallkonsortium Rhein-Neckar (Stroke Consortium Rhine-Neckar)

Role: collaborator

NCT04534998Phase 2Unknown

Robotic-assisted vs. Open Partial Nephrectomy

Role: collaborator

NCT02883699Not ApplicableCompleted

Individually Tailored Training Prescriptions in Cancer Patients: The TOP Study

Role: collaborator

NCT01005043Phase 1Completed

Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma

Role: collaborator

NCT02907658Not ApplicableUnknown

Efficacy of Internet Use Disorder Prevention

Role: collaborator

NCT00259571Phase 2Withdrawn

Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.

Role: collaborator

NCT00259545Phase 2Completed

Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis

Role: collaborator

NCT00259558Phase 2Completed

Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis

Role: collaborator

All 10 trials loaded